A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
Stefano Cascinu(Vita-Salute San Raffaele University), Giuseppina Catalano(Unknown), L. Frontini, Luciano Giuliodori(Ospedale di Spoleto), Rosa Rita Silva(Ospedale di Spoleto), Sandro Barni, Paolo Giordani(University of Genoa), R. Cellerino, Roberto Labianca(Ospedale Papa Giovanni XXIII), M.A. Pessi(Ospedale San Carlo), G. Pancera, G Luporini, E. Piazza(Luigi Sacco Hospital), Vittorio Fusco(Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo)
Cited by 82
Related Papers
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k
Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials
|Journal of Clinical Oncology|2008|582
DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
|JNCI Journal of the National Cancer Institute|2011|527